Alnylam Pharmaceuticals Inc. (ALNY) Company Report July 28, 2022, 05:26 UTC 63 0 comments New Form 10-Q for Alnylam Pharmaceuticals, Inc. Comment Full text
Pfizer Inc. (PFE) Company Report July 28, 2022, 03:46 UTC 71 0 comments Pfizer Inc. - Second Quarter 2022 Comment Full text
Innoviva Inc. (INVA) Company Report July 27, 2022, 13:49 UTC 67 0 comments New Form 10-Q for Innoviva, Inc. Comment Full text
Myriad Genetics, Inc. (MYGN) Company Report July 27, 2022, 13:17 UTC 66 0 comments New Form 8-K for Myriad Genetics, Inc. Comment Full text
Mustang Bio, Inc. (MBIO) Company Report July 27, 2022, 05:05 UTC 64 0 comments Mustang Bio Announces First Patient Successfully Treated by Ex Vivo Lentiviral Gene Therapy to Treat RAG1 Severe Combined Immunodeficiency Comment Full text
Supernus Pharmaceuticals (SUPN) Company Report July 26, 2022, 13:45 UTC 67 0 comments New Form 8-K for Supernus Pharmaceuticals Comment Full text
Iveric Bio (ISEE) Company Report July 26, 2022, 13:21 UTC 65 0 comments New Form 10-Q for Iveric Bio Comment Full text
Rigel Pharmaceuticals, Inc. (RIGL) Company Report July 26, 2022, 05:32 UTC 66 0 comments Rigel Announces Conference Call and Webcast to Report Second Quarter 2022 Financial Results and Business Update Comment Full text
INCY Company Report July 22, 2022, 14:55 UTC 68 0 comments Weekly Summary Alert for Incyte Corporation Comment Full text
RLMD Company Report July 21, 2022, 06:27 UTC 64 0 comments Relmada Therapeutics Appoints Biopharmaceutical Marketing and Commercial Planning Veteran John Hixon as Head of Commercial Comment Full text